The Double Edged Sword of Glioblastoma Treatment Researchers at the University of Technology Sydney, Harvard, and Henan universities have developed a "double punch" nanozyme platform capable of illuminating hidden tumor cells during surgery and destroying microscopic cancer left behind afterward.
This innovative approach addresses two major challenges inherent to glioblastoma treatment: the difficulty in completely removing visible tumors while avoiding damage to surrounding brain tissue, and the blood brain barrier's restrictive effects on drug delivery.
The nanozyme platform's design allows for a precise guide during surgery. A thin, two dimensional sheet covered with individual atoms can be placed one at a time using semiconductor manufacturing methods.